Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells

Toxicology and Applied Pharmacology
Sung Hun KimYong Keun Kim

Abstract

The present study was undertaken to determine the role of the mitogen-activated protein kinase (MAPK) subfamilies in cell death induced by PPARgamma agonists in osteoblastic cells. Ciglitazone and troglitazone, PPARgamma agonists, resulted in a concentration- and time-dependent cell death, which was largely attributed to apoptosis. But a PPARalpha agonist ciprofibrate did not affect the cell death. Ciglitazone caused reactive oxygen species (ROS) generation and ciglitazone-induced cell death was prevented by antioxidants, suggesting an important role of ROS generation in the ciglitazone-induced cell death. ROS generation and cell death induced by ciglitazone were inhibited by the PPARgamma antagonist GW9662. Ciglitazone treatment caused activation of extracellular signal-regulated kinase (ERK) and p38. Activation of ERK was dependent on epidermal growth factor receptor (EGFR) and that of p38 was independent. Ciglitazone-induced cell death was significantly prevented by PD98059, an inhibitor of ERK upstream kinase MEK1/2, and SB203580, a p38 inhibitor. Ciglitazone treatment increased Bax expression and caused a loss of mitochondrial membrane potential, and its effect was prevented by N-acetylcysteine, PD98059, and SB203580. Cigl...Continue Reading

Citations

Mar 28, 2009·PPAR Research·Eoin J CotterPeter P Doran
Jul 7, 2011·International Journal of Molecular Sciences·Zhiyuan FengXinhua Sun
Sep 29, 2007·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A Grey
Sep 17, 2010·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Tamás Roszer
Aug 2, 2007·Expert Opinion on Therapeutic Targets·Efstathia PapageorgiouMichael Koutsilieris
Jan 25, 2007·Expert Opinion on Investigational Drugs·Costas GiaginisStamatios Theocharis
May 25, 2007·Fundamental & Clinical Pharmacology·Costas GiaginisStamatios Theocharis
Jun 26, 2010·Pharmacotherapy·Daniel M Riche, S Travis King
Nov 6, 2008·Biochemical Pharmacology·F PennaP Costelli
Mar 9, 2007·European Journal of Pharmacology·Marina Sánchez-HidalgoCatalina Alarcón de la Lastra
Oct 12, 2010·AIDS Research and Human Retroviruses·Eoin J CotterPeter P Doran
Sep 18, 2007·Molecular Reproduction and Development·Fernanda ParborellMarta Tesone
Sep 24, 2010·Cell Biochemistry and Function·Marina MaggioraRosa Angela Canuto
Mar 11, 2015·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Miao DuanGang Yuan
Aug 2, 2008·Diabetes, Obesity & Metabolism·Andrew Grey
Jan 3, 2012·Environmental Toxicology and Pharmacology·Jing QiuShuzhu Gu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.